BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27633725)

  • 1. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
    Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
    Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
    Well L; Rausch VH; Adam G; Henes FO; Bannas P
    Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
    [No Abstract]   [Full Text] [Related]  

  • 3. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
    Davenport MS; Caoili EM; Kaza RK; Hussain HK
    Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    Allen BC; Ho LM; Jaffe TA; Miller CM; Mazurowski MA; Bashir MR
    AJR Am J Roentgenol; 2018 Jun; 210(6):1266-1272. PubMed ID: 29629800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
    Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
    Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
    Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL
    AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?
    Vernuccio F; Cannella R; Gozzo C; Greco V; Midiri M; Furlan A; Tang A; Brancatelli G
    Abdom Radiol (NY); 2020 Aug; 45(8):2409-2417. PubMed ID: 32435849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
    Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
    Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
    Taibbi A; Brancatelli G; Matranga D; Midiri M; Lagalla R; Bartolotta TV
    Diagn Interv Radiol; 2019 Mar; 25(2):95-101. PubMed ID: 30860073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial.
    McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR
    Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.
    Luetkens JA; Kupczyk PA; Doerner J; Fimmers R; Willinek WA; Schild HH; Kukuk GM
    Eur Radiol; 2015 Nov; 25(11):3207-13. PubMed ID: 25903709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Stocker D; Hectors S; Bane O; Vietti-Violi N; Said D; Kennedy P; Cuevas J; Cunha GM; Sirlin CB; Fowler KJ; Lewis S; Taouli B
    Eur Radiol; 2021 Dec; 31(12):9306-9315. PubMed ID: 34043055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Song JS; Choi EJ; Park EH; Lee JH
    Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
    Gruber L; Rainer V; Plaikner M; Kremser C; Jaschke W; Henninger B
    Eur Radiol; 2018 May; 28(5):2013-2021. PubMed ID: 29264636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
    Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
    Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know.
    Well L; Weinrich JM; Adam G; Bannas P
    Rofo; 2018 Jan; 190(1):20-30. PubMed ID: 29156475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.